Shares of McKesson (NYSE:MCK) traded at a new 52-week high today of $100.11. This new high was reached on approximately average trading volume as 1.1 million shares traded hands, while the average 30-day volume is approximately 1.2 million shares.
Over the past year, McKesson has traded in a range of $74.89 to $100.11 and is now at $99.66, 33% above that low. The 200-day and 50-day moving averages have moved 0.24% higher and 0.59% higher over the past week, respectively.
There is potential upside of 7.3% for shares of McKesson based on a current price of $99.66 and an average consensus analyst price target of $106.95. The stock should discover initial support at its 50-day moving average (MA) of $94.79 and subsequent support at its 200-day MA of $90.79.
McKesson Corporation distributes pharmaceuticals, medical-surgical supplies, and and health and beauty care products throughout North America. The Company also develops, implements, and supports software that facilitates the integration of data throughout the health enterprise. In addition, McKesson offers analytic, care management, and patient solutions for payers.